LANZA, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 10.960
AS - Asia 5.476
EU - Europa 5.098
SA - Sud America 992
AF - Africa 101
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
Totale 22.642
Nazione #
US - Stati Uniti d'America 10.735
SG - Singapore 2.244
IT - Italia 1.680
CN - Cina 1.635
BR - Brasile 840
DE - Germania 785
HK - Hong Kong 551
UA - Ucraina 499
PL - Polonia 475
GB - Regno Unito 376
TR - Turchia 374
FI - Finlandia 300
FR - Francia 267
VN - Vietnam 253
RU - Federazione Russa 192
SE - Svezia 188
MX - Messico 101
CA - Canada 97
ID - Indonesia 97
IN - India 97
NL - Olanda 84
AR - Argentina 69
ES - Italia 50
AT - Austria 46
ZA - Sudafrica 46
JP - Giappone 43
BE - Belgio 42
BD - Bangladesh 41
IQ - Iraq 26
EC - Ecuador 25
LT - Lituania 19
CH - Svizzera 17
CZ - Repubblica Ceca 17
PK - Pakistan 17
MA - Marocco 15
PY - Paraguay 12
RO - Romania 12
AU - Australia 10
BG - Bulgaria 10
CO - Colombia 10
CL - Cile 9
IE - Irlanda 9
IR - Iran 9
JO - Giordania 9
TN - Tunisia 9
VE - Venezuela 9
EG - Egitto 8
KR - Corea 8
UY - Uruguay 8
UZ - Uzbekistan 8
KZ - Kazakistan 7
AL - Albania 6
DO - Repubblica Dominicana 6
DZ - Algeria 6
IL - Israele 6
PH - Filippine 6
GR - Grecia 5
JM - Giamaica 5
PE - Perù 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
BO - Bolivia 4
DK - Danimarca 4
HN - Honduras 4
KE - Kenya 4
BH - Bahrain 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
HU - Ungheria 3
MY - Malesia 3
NP - Nepal 3
OM - Oman 3
RS - Serbia 3
SV - El Salvador 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BY - Bielorussia 2
EU - Europa 2
GH - Ghana 2
KG - Kirghizistan 2
KH - Cambogia 2
LB - Libano 2
LU - Lussemburgo 2
NI - Nicaragua 2
PT - Portogallo 2
SC - Seychelles 2
TD - Ciad 2
TH - Thailandia 2
TL - Timor Orientale 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BW - Botswana 1
CU - Cuba 1
ET - Etiopia 1
GA - Gabon 1
GL - Groenlandia 1
GY - Guiana 1
KW - Kuwait 1
Totale 22.632
Città #
Singapore 1.213
Ashburn 1.112
Woodbridge 1.011
Fairfield 1.003
Chandler 627
Santa Clara 564
Jacksonville 560
Houston 553
Hong Kong 546
Beijing 538
Ann Arbor 526
Warsaw 460
Seattle 384
Wilmington 339
Cambridge 297
Ferrara 278
Izmir 227
Munich 222
New York 209
Nanjing 192
Dallas 188
Los Angeles 186
Dearborn 164
Princeton 153
Milan 142
Boardman 106
San Diego 103
Rome 95
Helsinki 94
Shanghai 92
Turku 88
São Paulo 86
Ho Chi Minh City 79
Jakarta 78
Bologna 73
Nanchang 66
Mexico City 65
Hefei 64
London 59
Shenyang 58
Chicago 53
Denver 45
Nuremberg 45
Tianjin 45
The Dalles 44
Hanoi 43
Buffalo 41
Brussels 36
Tokyo 36
Amsterdam 35
Poplar 35
Stockholm 34
Frankfurt am Main 33
Kunming 33
Brooklyn 32
Changsha 32
Moscow 32
Redwood City 32
Bremen 31
Boston 30
Palermo 30
Jinan 29
Montreal 29
Naples 29
Toronto 29
Hebei 28
Phoenix 28
Jiaxing 27
Johannesburg 27
Dong Ket 26
Manchester 26
Rio de Janeiro 26
San Francisco 26
Ankara 25
Atlanta 25
Orem 25
Falkenstein 24
Addison 23
Chennai 23
Norwalk 23
Catania 22
Columbus 22
Falls Church 22
San Mateo 22
Ningbo 20
Orange 20
Guangzhou 18
Mountain View 18
Washington 18
Zhengzhou 18
Belo Horizonte 17
Brasília 17
Florence 17
Padova 17
Taizhou 17
Ottawa 16
Vienna 16
Tappahannock 15
Auburn Hills 14
Brno 14
Totale 14.535
Nome #
Adenoma-carcinoma del retto-colon. Linee guida e criteri diagnostici minimi. 986
Merkel cell carcinomas arising in autoimmune disease affected patients treated with biologic drugs including anti-TNF 369
Anti-miR-135b in colon cancer treatment: Results from a preclinical study. 308
Gene expression changes in progression of cervical neoplasia revealed by microarray analysis of cervical neoplastic keratinocytes 307
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma 262
Perdita di espressione delle proteine MLH1, MSH2, MSH6 ed instabilità dei microsatelliti nel carcinoma dell'endometrio 247
PML at Mitochondria-Associated Membranes Is Critical for the Repression of Autophagy and Cancer Development 240
A New Case of Syringocystadenocarcinoma Papilliferum: A Rare Pathology for a Wide-Ranging Comprehension 236
Gastrointestinal stromal tumors and other malignancies: A case series 235
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses 230
Histologic and sonographic features of holmium laser in the treatment of chronic venous disease 228
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer 215
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 215
Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2 210
Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25 205
Anti-miR-135b in colon cancer treatment: Results from a preclinical study. 204
Fhit protein expression in human gastric cancer and related precancerous lesions 198
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer 195
N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration 191
An apparently untreatable ulcer of the face 189
Colorectal tumors: The histology report 187
Loss of cortical GABA terminals in Unverricht–Lundborg disease 187
MicroRNA involvement in hepatocellular carcinoma 186
MIR-501 DEPLETION INDUCES CELL CYCLE INHIBITION BY MTOR AND P53 MODULATION IN RENAL CARCINOMA 185
Detection of DNA mutations in urine of patients with prostate cancer by NGS technology 185
Adjuvant chemotherapy in colorectal cancer patients with microsatellite instability - Response 184
Evaluation of the Role of BRAFV600E Somatic Mutation on Papillary Thyroid Cancer Disease Persistence: A Prospective Study 184
The role of immunohistochemistry in the identification of BRAF V600E mutated colorectal cancer 179
Clinical and technical validation of a genomic classifier (ColoPrint) for predicting outcome of patients with stage II colon cancer. 178
Feasibility of sentinel lymph node (sln) biopsy in colic cancer 178
Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients 178
Amelanotic metastasing melanoma mimicking lung cancer 177
microRNA-135b promotes cancer progression acting as a downstream effector of oncogenic pathways in colon cancer 173
MiR501-5p stimulating the activity of mToR may result a risk factor for a poor prognosis of clear cell kidney carcinoma 173
Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer 172
The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis 165
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer 164
Analysis of MLH1 promoter methylation in colorectal carcinomas with microsatellite instability 164
Role of MGMT methylation status at time of diagnosis and recurrence for patients with glioblastoma: clinical implications 164
Biologic characterization of hereditary non-polyposis colorectal cancer: Nuclear ploidy, AgNOR count, microvessel distribution, oncogene expression, and grade-related parameters 162
SLUG/HIF1-α/miR-221 regulatory circuit in endometrial cancer 160
Segmented filamentous bacteria-like organisms in histological slides of ileo-cecal valves in patients with ulcerative colitis 159
The prognostic role of gender and MGMT methylation status in glioblastoma patients: The female power 158
Pathologic and molecular features of BRAF mutated colorectal adenocarcinomas 158
Immunohistochemical pattern of MLH1/MSH2 expression is related to clinical and pathological features in colorectal adenocarcinomas with microsatellite instability. 157
Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells 157
Genomic classifier coloprint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factors 157
Class 1, 2, and 3 BRAF-Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular Characterization 155
Feasibility of sentinel lymph node (sln) byopsy in colic cancer 154
Assessment of MLH1 promoter methylation and BRAF gene mutation in colorectal carcinomas with microsatellite instability 153
Frequent aberrant methylation of the CDH4 gene-promoter in human colorectal and gastric cancer 153
Analysis of BRAF Gene Mutation and MLH1 Promoter Methylation in MSI-H Colorectal Carcinomas with Loss of MLH1 Protein Expression 152
Medullary-type poorly differentiated adenocarcinoma of the large bowel: A distinct clinicopathologic entity characterized by microsatellite instability and improved survival 151
Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis 150
Ependymomas, Malignant Tumors of Pancreatic Islets, and Osteosarcomas Induced in Hamsters by BK Virus, a Human Papovavirus 148
p53 Expression in colorectal cancer: Relation to tumor type, DNA ploidy pattern, and short-term survival 148
Oncogenic role of miR-483-3p at the IGF2/483 locus 148
Differential expression of A3 adenosine receptors in colorectal cancer and related mucosa: a mirror in blood cells. 147
MicroRNA-135b promotes cancer progression acting as a downstream effector of oncogenic pathways in colon cancer 147
Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study 145
Multigene methylation analysis of gastrointestinal tumors: TPEF emerges as a frequent tumor-specific aberrantly methylated marker that can be detected in peripheral blood 141
Relapses of primary cutaneous anaplastic large-cell lymphoma in a female immunocompetent patient with persistent chlamydophila pneumoniae and human herpesvirus 8 infection 141
Identification and classification of Hereditary Nonpolyposis Colorectal Cancer (Lynch syndrome): adapting old concepts to recent advancements. Report from the Italian Association for the Study of Hereditary Colorectal Tumors Consensus Group 138
Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer 138
MGMT expression in colorectal cancer: relation to clinicopathologic and molecular features 137
Immunohistochemical evaluation of mismatch repair proteins in colorectal carcinoma: the AIFEG/GIPAD proposal 136
Modulation of mismatch repair and genomic stability by miR-155 135
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer 134
p53 protein expression in the colorectal adenoma-carcinoma sequence 130
Sensitive and specific detection of lung cancer DNA in bronchial washing by a novel methylation-specific droplet digital PCR 130
SARS-CoV-2 nucleocapsid-protein and ultrastructural modifications in small bowel of a four week negative COVID-19 patient 130
The first two years of colorectal cancer screening in Ferrara, Italy 128
null 126
Hsa-microRNA-1249-3p/Homeobox A13 axis modulates the expression of β-catenin gene in human epithelial cells 124
Microsatellite instability in multiple colorectal tumors 123
Effect of vaccination with autologous tumor-loaded dendritic cells on intratumoral regulatory T cells in metastatic melanoma patients 123
Targeted Sequencing Approach For Prostate Cancer Using Ion Torrent Personal Genome Machine (PGM ™) Platform 123
Espressione del gene MGMT nel carcinoma colo-rettale: correlazioni cliniche, patologiche e biomolecolari 123
Anti-miR-135b in colon cancer treatment 122
Instabilità dei microsatelliti ed espressione delle proteine del mismatch repair nel carcinoma endometriale 120
miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis 119
A microRNA expression signature of human solid tumors defines cancer gene targets 118
PML at mitochondria-associated membranes governs a trimeric complex with NLRP3 and P2X7R that modulates the tumor immune microenvironment 117
Valutazione di parametri prognostici nel carcinoma del colon-retto. II. Ploidia mediante citometria a flusso. 117
Colorectal cancer screening in Ferrara: Results in early (2005-2009) and late (2009-2013) screening periods and surgical treatment of the screenees versus pre-screening (2003-2005) unselected population. 117
P3.03-22 IL-1β as a New Early Predictive Biomarker for Non-Small Cell Lung Cancers Outcome 117
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 115
Epigenetic Regulation: A Link between Inflammation and Carcinogenesis 115
Evaluation of the Synovial Effects of Biological and Targeted Synthetic DMARDs in Patients with Psoriatic Arthritis: A Systematic Literature Review and Meta-Analysis 113
Inflammatory Microenvironment in Early Non-Small Cell Lung Cancer: Exploring the Predictive Value of Radiomics 113
null 113
Cost-effectiveness of colonoscopy colorectal cancer (CRC) screening in asymptomatic increased risk subjects 112
Late-onset intrauterine growth restriction and HHV-6 infection: A pilot study 111
Screening patologico per la identificazione dei tumori colo-rettali con deficit del DNA mismatch repair 110
Prognostic value of microsatellite instability and intratumor activated cytotoxic lymphocytes in colon cancer 110
Methylenetetrahydrofolate reductase 677 C -> T polymorphism and risk of proximal colon cancer in North Italy 110
Detection of disease-causing mutations in prostate cancer by NGS sequencing 110
Prognostic value of flow cytometric DNA ploidy in colorectal cancer 108
Mitochondrial Ca2+ Signaling in Health, Disease and Therapy 108
Successful fenofibrate therapy for severe and persistent hypertriglyceridemia in a boy with cirrhosis and glycerol-3-phosphate dehydrogenase 1 deficiency 107
Totale 16.914
Categoria #
all - tutte 104.935
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.935


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.372 0 0 0 0 0 209 93 232 78 313 264 183
2021/20221.558 79 177 109 64 79 75 67 107 57 139 123 482
2022/20231.663 171 111 73 199 217 200 90 157 207 40 113 85
2023/20241.273 101 135 77 44 107 203 84 104 44 55 66 253
2024/20254.416 128 122 327 229 441 427 256 238 718 421 671 438
2025/20265.529 1.089 469 866 1.324 1.597 184 0 0 0 0 0 0
Totale 22.965